Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
834,731,296
-
Number of holders
-
127
-
Total 13F shares, excl. options
-
25,280,563
-
Shares change
-
+281,577
-
Total reported value, excl. options
-
$1,065,074,046
-
Value change
-
+$13,001,072
-
Put/Call ratio
-
1.14%
-
Number of buys
-
52
-
Number of sells
-
-65
-
Price
-
$42.14
Significant Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q2 2017
149 filings reported holding RDY - DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share as of Q2 2017.
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) has 127 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25,280,563 shares
of 834,731,296 outstanding shares and own 3.03% of the company stock.
Largest 10 shareholders include Fisher Asset Management, LLC (5,599,434 shares), ROYAL BANK OF CANADA (3,460,613 shares), COMMONWEALTH BANK OF AUSTRALIA (3,452,533 shares), AQR CAPITAL MANAGEMENT LLC (1,517,158 shares), VANGUARD GROUP INC (1,472,774 shares), BlackRock Inc. (1,288,556 shares), HSBC HOLDINGS PLC (638,590 shares), STATE STREET CORP (629,903 shares), DIMENSIONAL FUND ADVISORS LP (573,738 shares), and NORTHERN TRUST CORP (427,419 shares).
This table shows the top 127 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.